STATE STREET CORP

Position in AKBA — Akebia Therapeutics, Inc.

CIK 93751 BOSTON, MA

Back to AKBA Full portfolio

Position in AKBA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$16,143,468

-$5,893,505 QoQ

Shares Held

11,614,006

-15.1% QoQ

Ownership

4.19%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 11% Shared 0% None 89%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

STATE STREET CORP holds $7,491,843,141 across 54 Drug Manufacturers - Specialty & Generic names. AKBA ranks #28 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	19,324,401	$2,284,337,442
2	UTHR	UNITED THERAPEUTICS Corp	1,843,963	$1,093,433,179
3	VTRS	Viatris Inc	52,233,699	$705,677,273
4	NBIX	Neurocrine Biosciences Inc	4,354,526	$573,665,255
5	TEVA	Teva Pharmaceutical Industries Ltd	17,790,020	$535,835,402
6	ELAN	Elanco Animal Health Inc	15,336,479	$367,001,942
7	ALKS	Alkermes plc.	9,465,286	$334,692,512
8	LNTH	Lantheus Holdings, Inc.	2,429,803	$184,300,557

All Filings in AKBA

Export CSV

27 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$16,143,468	11,614,006	-15.1%	Shares	Sole	2026-05-12
2026-03-31	$16,143,468	11,614,006	-15.1%	Shares	Defined	2026-05-15
2025-12-31	$22,036,973	13,687,561	—	Shares	Sole	2026-02-09
2025-12-31	$22,036,973	13,687,561	+15.6%	Shares	Defined	2026-02-13
2025-09-30	$32,336,219	11,844,769	+48.1%	Shares	Defined	2025-11-14
2025-06-30	$29,109,636	7,997,153	+17.5%	Shares	Defined	2025-08-14
2025-03-31	$13,067,149	6,805,807	+7.9%	Shares	Defined	2025-05-15
2024-12-31	$11,978,926	6,304,698	+83.8%	Shares	Defined	2025-02-14
2024-09-30	$4,528,295	3,430,527	+24.9%	Shares	Defined	2024-11-14
2024-06-30	$2,802,184	2,747,240	+322.4%	Shares	Defined	2024-08-14
2024-03-31	$1,190,140	650,350	+6.5%	Shares	Defined	2024-05-15
2023-12-31	$757,082	610,550	-7.0%	Shares	Defined	2024-02-14
2023-09-30	$748,353	656,450	+4.9%	Shares	Defined	2023-11-14
2023-06-30	$572,835	626,050	-9.6%	Shares	Defined	2023-08-14
2023-03-31	$387,988	692,836	+21.1%	Shares	Defined	2023-05-15
2022-12-31	$330,007	571,936	0.0%	Shares	Defined	2023-05-15
2022-09-30	$180,731	571,936	-0.3%	Shares	Defined	2022-11-15
2022-06-30	$202,578	573,876	-95.0%	Shares	Defined	2022-08-15
2022-03-31	$8,248,544	11,488,224	-2.2%	Shares	Defined	2022-05-16
2021-12-31	$26,540,221	11,743,461	-25.9%	Shares	Defined	2022-02-14
2021-09-30	$45,666,512	15,856,428	+13.2%	Shares	Defined	2021-11-15
2021-06-30	$53,085,154	14,006,637	-17.8%	Shares	Defined	2021-08-16
2021-03-31	$57,694,535	17,044,176	-24.2%	Shares	Defined	2021-07-09
2020-12-31	$62,934,295	22,476,534	+46.5%	Shares	Defined	2021-02-16
2020-09-30	$38,504,582	15,340,471	+206.1%	Shares	Defined	2020-11-10
2020-06-30	$68,063,476	5,012,038	+46.7%	Shares	Defined	2020-08-14
2020-03-31	$25,900,329	3,416,930	—	Shares	Defined	2020-06-19
No filing history on record for this holder in this stock.